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Abstract 
Increasing global demand for food has generated a need for new strategies to feed a 
fast-growing population. Oceans appear as a sustainable solution, providing 
alternative sources of food such as macroalgae. These sea vegetables have high 
nutritional value and provide functional and health benefits. The sugar kelp 
Saccharina latissima is an emerging edible seaweed used mainly for human 
consumption. Although much is known about its biochemical compositions its 
lipidome remains unexplored. The aim of the present study was to characterize the 
polar lipid profile of S. latissima using a lipidomic-mass spectrometry HILIC-LC-MS 
based analysis. This approach allowed the identification of 197 molecular species of 
polar lipids, including glycolipids, phospholipids and betaine lipids. Several 
molecular species identified are carriers of polyunsaturated fatty acids with nutritional 
value and have been reported with anti-inflammatory, anti-microbial and anti-
proliferative activity. Saccharina latissima is an emerging candidate to promote blue 
biotechnology inspired by the ocean. 
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Highlights 
 
 Saccharina latissima is a promising source of lipid for food and feed 
industries 
 Lipidome of S. latissima reveals the presence of potential bioactive 
compounds 
 High nutritional value of S. latissima as source of polyunsaturated fatty acids 
 Lipids from S. latissima could be incorporated in new high-value products 
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1. Introduction 
The increasing world population has driven a surge on the search for new nutritional 
sources and a growing concern for healthiness and fitness have led consumers to 
demand healthier foods. One way to match these demands is looking for alternative 
solution in marine environments [1]. Oceans occupy the largest area of the biosphere, 
although most of them remain yet unexplored. Marine environments harbor a vast 
array of organisms providing them with unique biological properties. This is the case 
of macroalgae, which are adapted to diverse environments, sometimes even extreme 
[2], and to natural fluctuations on biotic and abiotic conditions (e.g. temperature, 
light, availability of nutrients, interaction with other species) [3]. This plasticity is 
reflected in their chemical phenotype and in their valuable primary and secondary 
metabolites [4–6], namely polysaccharides, protein, mineral, phenolic components 
and lipids [6,7]. Although, lipid content in macroalgae is relatively low, it includes 
relevant lipids, such as glycolipids and n-3 fatty acids which have already been 
recognized by their bioactive and nutritional value [8,9]. The role of dietary lipids in 
health, wellbeing, to protect or as potential therapeutic targets for disease has been 
increasingly recognized in the last decades [10–12]. In this sense, several studies have 
identified bioactive compounds in polar lipids isolated from macroalgae [8,13], as 
well as relevant health benefits associated to their consumption [6,13]. Therefore, the 
characterization of macroalgae lipidome and the identification of potential bioactive 
compounds are essential for their bioprospection, for finding healthful resources, as 
well as to find alternative sources of lipids for food, feed or to be incorporated in new 
high-value products. 
The sugar kelp Saccharina latissima is a native European Atlantic macroalgae used 
mainly for human consumption [14], but due to development of cultivation also with 
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emerging applications in animal feed and potential for production of renewable fuels 
[2,15]. This edible seaweed has been recognized by its high concentration of essential 
minerals (e.g. iodine, calcium), sugars (e.g. glucose and mannitol), protein and high 
value compounds, such as phenolics (e.g. phlorotannins), fucoidan, fucoxanthin and 
alginates [5,15]. However, in spite of its recognized potential, the lipidome of S. 
latissima is yet to be unraveled and it is still limited to the characterization of fatty 
acid profile [16]. The use of mass spectrometry based approaches applied to lipidomic 
analysis have brought new insights in the survey of macroalgae lipidome and the 
identification of compounds with potential bioactivity [8,12,17]. In this sense, polar 
lipids identified in the lipidome of macroalgae, namely glycolipids and phospholipids, 
have been recognized as a natural source of polyunsaturated fatty acids (PUFA) and 
bioactive compounds [18,19]. 
The main goal of the present study was to identify and to characterize the polar lipid 
profile of S. latissima, using hydrophilic interaction liquid chromatography-
electrospray ionization-mass spectrometry (HILIC–ESI–MS and M/MS). This 
analysis aims to elucidate the nutritional valued of this seaweed, in order to promote 
its valorization and to prospect potential bioactive lipid compounds with health 
benefits, which can foster the valorization and consumption of this macroalga as a 
functional food and/or as a source of add value compounds for nutraceutics. 
 
2. Materials and methods 
2.1. Sampling 
Samples of S. latissima were cultivated at Seaweed Energy Solutions´ farm 
Taraskjæra at Frøya, Norway (N 63° 42.279', E 8° 52.232’) at a depth of approx. 2 m, 
from early February to end of May 2016. Biomass was harvested on 23rd – 24th of 
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May 2016. After collection, 2 kg biomass samples were washed in filtered seawater, 
frozen using individual quick freezing (IQF) (vacuum packed) and stored at – 20 ºC. 
Before analysis, samples were frozen to – 80 ºC overnight and freeze-dried by 
SINTEF Ocean (Norway) during 2-3 d at – 50 ºC. The dried biomass was milled in a 
Mikro-Feinmühle-Culatti (IKA-Labortechnik). Storage and shipping for further 
processing were performed at -18 °C. 
 
2.2. Lipid extraction 
The Bligh and Dyer [20] method was used to extract total lipids from S. latissima 
samples. Freeze-dried samples were homogenized in a mortar and pestle to obtain 
small-sized flakes. A total biomass of 250 mg of macroalga was mixed with 2.5 mL 
of methanol and 1.25 mL of chloroform in glass centrifuge tubes. Following vigorous 
homogenization, samples were incubated on ice for 2 h and 30 minutes on an orbital 
shaker. Samples were centrifuged at 2000 rpm for 10 minutes at room temperature 
and the organic phase contained lipids was collected. Lipid extraction was repeated 
twice in the macroalgal biomass. In order to resolve a two-phase system, 2.3 mL of 
ultrapure water was added to the organic phase and after that the samples were 
centrifuged at 2000 rpm for 10 minutes at room temperature. The lipids recovered 
from the organic lower phase were dried under a nitrogen stream and preserved at −20 
°C for further analysis. The final weight of the crude lipid extract was determined by 
gravimetry. 
2.3. Fractionation of lipid extract 
In order to isolate polar lipids, total lipid extracts were fractionated using a 
modification of Pacetti’s method according to Rey et al. method [21]. Fractionation 
was performed by solid-phase extraction using a glass column with 500 mg of silica 
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gel (40–60 μm, 60 Å, Åcros Organics). Column was activated with 6 mL of n-hexane 
and then 3 mg of total lipid extract was applied after to be dissolved on 300 μL of 
chloroform. Subsequently, the following sequential elution was performed to separate 
lipid fractions: 5 mL of chloroform, 8 mL of diethyl ether:acetic acid (98:2, v/v), 6 mL 
of acetone:methanol (9:1, v/v) and 6 mL of methanol. Total lipid extracts were 
fractionated in four lipid fractions: fraction 1 (rich in neutral lipids), fraction 2 (rich in 
pigments), fraction 3 (rich in glycolipids) and fraction 4 (rich in phospholipids and 
betaine lipids). Fractions 3 and 4 were recovered separated and dried under nitrogen 
stream and stored at –20 °C prior to analysis by HILIC−LC−MS. 
2.4. Hydrophilic interaction liquid chromatography–mass spectrometry 
(HILIC-LC-MS) 
Total lipid extracts and fractions were analyzed by hydrophilic interaction liquid 
chromatography on a high-performance liquid chromatography (HPLC) Thermo 
Scientific AccelaTM with an autosampler coupled online to a Q-Exactive hybrid 
quadrupole mass spectrometer (Thermo Fisher, Scientific, Bremen, Germany). 
Analyses were performed using a solvent system with two mobile phases. A mobile 
phase A consisted of water, acetonitrile and methanol (25%, 50%, 25%), with 1 mM 
ammonium acetate, and a mobile phase B consisted of acetonitrile and methanol 
(60%, 40%), with 1 mM ammonium acetate. Solvent system started with 0% of 
mobile phase A, which was held isocratically for 8 minutes, a linear increase to 60% 
of mobile phase A was applied within 7 minutes and maintained for 15 minutes, 
returning to the initial conditions in 10 minutes. In order to analysis each sample by 
HILIC-LC-MS 10 µg of total lipid extract, 4 µL of phospholipid standards mix 
(dMPC - 0.02 µg, dMPE - 0.02 µg, , LPC - 0.02 µg, , dPPI - 0.08 µg, dMPG - 0.012 
µg, dMPS - 0.04 µg) and 86 µL of eluent B were introduced into the Ascentis Si 
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column HPLC Pore column (15 cm × 1 mm, 3 µm, Sigma-Aldrich) with a flow rate of 
40 µL minutes−1 at 30 ºC. Acquisition in the e Orbitrap® mass spectrometer was 
performed in positive (electrospray voltage 3.0 kV) and negative (electrospray voltage 
−2.7 kV) modes with high resolution with 70 000 and AGC target of 1e6, the 
capillary temperature was 250 ºC and the sheath gas flow was 15 U. In MS/MS 
experiments, a resolution of 17 500 and AGC target of 1e5 was used and the cycles 
consisted in one full scan mass spectrum and ten data-dependent MS/MS scans were 
repeated continuously throughout the experiments with the dynamic exclusion of 60 
seconds and intensity threshold of 1e4. Normalized collision energy™ (CE) ranged 
between 25, 30 and 35 eV. Data acquisition was performed using the Xcalibur data 
system (V3.3, Thermo Fisher Scientific, USA) [21,22]. 
In lipidomic studies normal phase (NP) or HILIC columns and reversed-phase C18 
columns have been used. The separation of lipids in these methods are based on 
different properties: NP or HILIC columns allow the separation based on their 
hydrophilicity, which is mainly dependent on the polar head properties, allowing the 
separation of different lipid classes in a single run. In reversed-phase C18 columns, 
lipids elute based on their hydrophobic properties, and thus separate the lipid species 
based on the number of carbons and the degree of unsaturation of the fatty acyl 
substituents, co-eluting ions of different classes [23]. 
Polar lipid molecular species were identified by recognition of ions observed in LC-
MS spectra (Supplementary Figure S12) and using the bioinformatic software 
MZmine 2.30. Molecular species were confirmed by interpretation of HILIC-ESI-
MS/MS fragmentation (see Supplementary Material for fragmentation interpretation) 
and mass accuracy (Qual Browser) of ≤ 5ppm (Supplementary Table S1). 
2.5. Fatty acid analysis by gas chromatography – mass spectrometry (GC-MS) 
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Fatty acids of total lipid extract were transmethylated to be analyzed by GC-MS. In 
order to obtain fatty acid methyl esters (FAMEs) 30 μg of lipid were transferred to a 
Pyrex glass tube and dried under nitrogen. Dry lipids were mixed with 1 mL of n-
hexane containing a C19:0 internal standard (0.746 μg mL-1, CAS number 1731-94-8, 
Merck, Darmstadt, Germany) and 200 μL of a methanolic solution of potassium 
hydroxide (2 mol L-1), followed by 2 minutes of homogenization. After this step, 2 
mL of a saturated solution of sodium chloride was added and the sample was 
centrifuged for 5 minutes at 2000 rpm to separate the phases. The organic (upper) 
phase containing the FAMEs was transferred to a microtube and completely dried 
under nitrogen [24]. FAMEs were then dissolved in 50 µL n-hexane and 2 μL of this 
solution was used for GC-MS analysis on an Agilent Technologies 6890 N Network 
chromatograph (Santa Clara, CA, USA) equipped with a DB-FFAP column (123-
3232, J & W Scientific, Folsom, CA, USA) with 30 m length, an internal diameter of 
0.32 mm and a film thickness of 0.25 μm. The GC was connected to an Agilent 5973 
Network Mass Selective Detector operating with an electron impact mode at 70 eV 
and scanning the mass range m/z 50 – 550 in a 1 s cycle in a full scan mode 
acquisition. The oven temperature was programmed from an initial temperature of 80 
°C, standing at this temperature for 3 minutes, followed by three consecutive linear 
increments to 160 °C at 25 °C minute−1, to 210 °C at 2 °C minute−1, and to 250 °C at 
30 °C minute−1. Temperature was maintained at 250 ºC for 10 minutes. The injector 
and detector temperatures were 220 and 280 °C, respectively. Helium was used as 
carrier gas at a flow rate of 1.3 mL minute−1 [22]. Fatty acid identification was 
performed by comparing their retention time and mass spectrum with MS spectra of 
the commercial FAME standards Supelco 37 and confirmed by interpretation of MS 
spectra [25]. Fatty acid amounts were calculated using calibration curves of FAME 
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standards Supelco 37 Component FAME Mix (ref. 47885-U, Sigma-Aldrich, 
Darmstadt, Germany) analyzed by GC-MS under the same conditions of FAMEs 
samples and using C19:0 (0.746 μg mL-1) as internal standard. Fatty acids were 
expressed both as total amount of fatty acid by biomass dry weight (DW) (µg mg DW 
-1) and as percentage (%). 
 
3. Results and Discussion 
The lipid extract of S. latissima represented 1.9% ± 0.4 (± SD) of total dry biomass. 
Analyses of lipid extracts by HILIC−LC−MS and MS/MS allowed the identification 
of polar lipids, such as glycolipids, phospholipids, arsenolipids and betaine lipids. 
Overall, 197 molecular species were identified, being grouped as follows: glycolipids 
(57), phospholipids (120), arsenolipids (12) and betaine lipids (8) (Supplementary 
Table S1). 
3.1. Glycolipid profile 
Glycolipids were distributed between galactolipids (monogalactosyl diacylglycerol, 
MGDG and digalactosyl diacylglycerol, DGDG) and sulfolipids (sulfoquinovosyl 
monoacylglycerol, SQMG and sulfoquinovosyl diacylglycerol, SQDG) classes. 
3.1.1 Galactolipids 
The neutral glycolipids identified corresponded to two classes of galactolipids, 
MGDG (Fig. 1) and DGDG (Fig. 2). Galactolipids were observed in HILIC-LC-MS 
spectra as positive [M + NH4]+ ions and their composition were confirmed by the 
interpretation of the MS/MS spectra (see Supplementary Figure S1 and S2, 
respectively). A total of 14 molecular species of MGDG were identified, being the 
most abundant species observed as [M + NH4]+ ions at m/z 744.6 and 746. 6 and 
assigned as MGDG (18:2/14:0) and MGDG (18:1/14:0), respectively (Fig. 1). 
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Regarding DGDG, a total of 15 molecular species were identified. The DGDG 
(20:5/18:4) correspond to [M + NH4]+ ion at m/z 976.6 and DGDG (20:5/18:3) 
correspond to m/z 978.6 represented the molecular species with higher relative 
abundance (Fig. 2). 
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Figure 1 Lipidomic profile of monogalactosyl diacylglycerol (MGDG) identified in 
Saccharina latissima samples. a) HILIC-ESI-MS spectrum of MGDG showing the 
molecular species detected as [M + NH4]+ ions. b) Molecular species of MGDG (C 
represents the total number of carbon atoms and N the total number of double bonds 
on the fatty acyl chains; bold m/z values correspond to the most abundant molecular 
species detected in HILIC-ESI-MS spectrum). 
  
 
[M+NH4]+
m/z Lipid species (C:N)
Fatty acyl chains
740.5305 MGDG(32:4) 18:4/14:0; 18:3/14:1; 16:4/16:0
742.5461 MGDG(32:3) 18:3/14:0; 16:3/16:0
744.5610 MGDG(32:2) 18:2/14:0; 18:1/14:1
746.5780 MGDG(32:1) 18:1/14:0; 16:1/16:0
748.5941 MGDG(32:0) 18:0/14:0; 16:0/16:0
768.5624 MGDG(34:4) 20:4/14:0; 18:4/16:0; 18:3/16:1;18:2/16:2
770.5755 MGDG(34:3) 18:3/16:0; 18:2/16:1; 18:1/16:2; 18:0/16:3; 20:3/14:0
772.5932 MGDG(34:2) 18:2/16:0; 18:1/16:1
774.6090 MGDG(34:1) 18:1/16:0
776.6229 MGDG(34:0) 18:0/16:0; 20:0/14:0
788.5296 MGDG(36:8) 18:4/18:4; 20:5/16:3
790.5458 MGDG(36:7) 18:4/18:3
814.5462 MGDG(38:9) 20:5/18:4; 20:4/18:5; 20:6/18:3
828.6591 MGDG(38:2) 22:2/16:0
a)
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740 760 780 800 820
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Figure 2 Lipidomic profile of digalactosyl diacylglycerol (DGDG) in Saccharina 
latissima samples. a) HILIC-ESI-MS spectrum of DGDG showing the molecular 
species detected as [M + NH4]+ ions; b) Molecular species of DGDG (C represents the 
total number of carbon atoms and N the total number of double bonds on the fatty 
acyl chains; bold m/z value corresponds to the most abundant molecular species 
detected in HILIC-ESI-MS spectrum). 
  
 
a)
b)
[M+NH4]+
m/z Lipid species(C:N)
Fatty acyl chains
902.5854 DGDG(32:4) 18:4/14:0; 20:4/12:0; 16:2/16:2
904.5981 DGDG(32:3) 18:3/14:0
906.6140 DGDG(32:2) 18:2/14:0
908.6299 DGDG(32:1) 18:1/14:0; 16:1/16:0; 18:0/14:1
932.6304 DGDG(34:3) 18:3/16:0; 18:2/16:1; 20:3/14:0
934.6461 DGDG(34:2) 18:2/16:0; 18:1/16:1; 20:1/14:1; 20:2/14:0
936.6613 DGDG(34:1) 18:1/16:0; 18:0/16:1; 20:1/14:0
938.6765 DGDG(34:0) 18:0/16:0; 20:0/14:0
950.5841 DGDG(36:8) 18:4/18:4; 20:5/16:3
952.5982 DGDG(36:7) 18:4/18:3; 20:5/16:2; 20:4/16:3; 20:6/16:1
956.6315 DGDG(36:5) 20:5/16:0; 18:3/18:2; 22:5/14:0; 20:4/16:1; 18:4/18:1
976.5979 DGDG(38:9) 20:5/18:4
978.6127 DGDG(38:8) 20:5/18:3; 20:4/18:4
980.6276 DGDG(38:7) 20:4/18:3; 20:5/18:2; 20:3/18:4; 20:6/18:1; 20:2/18:5
984.6610 DGDG(38:5) 20:4/18:1; 20:5/18:0; 20:1/18:4
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3.1.2 Sulfolipids  
Two classes of anionic glycolipids were identified by HILIC-LC-MS and MS/MS in 
negative mode. These classes were the SQDG and its lyso form SQMG (Fig. 3), both 
identified in the LC-MS spectra as [M – H]- ions (see Supplementary Figure S3). 
Three molecular species of SQMG were identified, and the most abundant was 
detected at m/z 555.3, corresponding to the SQMG (16:0) (Fig. 3). Concerning SQDG 
class, 25 molecular species were identified and the two most abundant were identified 
at m/z 819.5 and 821.5, corresponding to the[M – H]- ions of the SQDG (18:1/16:0) 
and SQDG (18:0/16:0), respectively (Fig. 3). 
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a)
b)
[M-H]-
m/z Lipid species (C:N)
Fatty acyl chains
737.4512 SQDG (28:0) 14:0/14:0
763.4662 SQDG (30:1) 16:1/14:0; 16:0/14:1
765.4815 SQDG (30:0) 16:0/14:0
779.4947 SQDG (31:0) 16:0/15:0; 17:0/14:0
785.4514 SQDG (32:4) 18:4/14:0
787.4663 SQDG (32:3) 18:3/14:0
791.4974 SQDG (32:1) 16:1/16:0; 18:1/14:0
793.5121 SQDG (32:0) 16:0/16:0; 18:0/14:0
805.5127 SQDG (33:1) 17:1/16:0; 18:1/15:0; 19:1/14:0
807.5264 SQDG (33:0) 17:0/16:0
813.4834 SQDG (34:4) 18:4/16:0; 20:4/14:0; 18:3/16:1; 18:2/16:2
815.4967 SQDG (34:3) 18:3/16:0
817.5134 SQDG (34:2) 18:2/16:0; 20:2/14:0; 18:1/16:1
819.5299 SQDG (34:1) 18:1/16:0
821.5437 SQDG (34:0) 18:0/16:0; 20:0/14:0
833.5430 SQDG (35:1) 19:1/16:0; 18:1/17:0
835.5604 SQDG (35:0) 19:0/16:0
837.4837 SQDG (36:6) 18:3/18:3
839.4970 SQDG (36:5) 20:5/16:0; 18:3/18:2; 20:4/16:1; 18:4/18:1
841.5135 SQDG (36:4) 20:4/16:0; 18:2/18:2; 18:3/18:1; 18:4/18:0 
843.5277 SQDG (36:3) 20:3/16:0; 18:2/18:1; 18:3/18:0 
845.5448 SQDG (36:2) 20:2/16:0; 18:1/18:1; 18:2/18:0
849.5760 SQDG (36:0) 20:0/16:0; 18:0/18:0; 22:0/14:0
859.4665 SQDG (38:9) 20:5/18:4
871.5601 SQDG (38:3) 22:3/16:0; 18:2/18:1; 18:3/18:0
[M-H]-
m/z Lipid species
Fatty acyl chain
555.2838 SQMG (16:0) 16:0
575.2532 SQMG (18:4) 18:4
581.3002 SQMG (18:1) 18:1
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d)
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Figure 3 Lipidomic profile of sulfolipids identified in Saccharina latissima samples. 
a) HILIC-ESI-MS spectrum of sulfoquinovosyl monoacylglycerol (SQMG) showing 
the molecular species detected as [M -H]- ions. b) HILIC-ESI-MS spectrum of 
sulfoquinovosyl diacylglycerol (SQDG) showing the molecular species detected as 
[M -H]- ions. c) Molecular species of SQMG. d) Molecular species of SQDG (C 
represents the total number of carbon atoms and N the total number of double bonds 
on the fatty acyl chains; bold m/z values correspond to the most abundant molecular 
species detected in HILIC-ESI-MS spectrum). 
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Glycolipids are abundant in photosynthetic organisms, being present in chloroplast 
and thylakoid membranes, where they play an essential role in physiological 
processes, as signal and regulatory molecules, and lipid trafficking between 
subcellular compartments [21,26]. This exclusive lipid class has sparked 
phytochemical researchers’ interest because it is a natural source of PUFA and 
bioactive compounds, with recognized healthful benefits [13,18,19]. Several 
functional bioactivities have been identified in glycolipids isolated from marine 
organisms including macroalga, namely anti-inflammatory, antioxidant, antimicrobial 
and antitumoral properties [8,17,27]. The presence of biological activity is strongly 
linked with the chemical features of molecular species [13]. In glycolipids, bioactivity 
has been associated with the structure of the sugar moiety, its anomeric configuration, 
the position of the glycerol linkage to the sugar, and specially with the length, number 
and position of double bonds in the acyl chains (Bruno et al., 2005; Zhang et al., 
2014). Several studies have identified biological activity in some molecular species of 
glycolipids, and reported that the presence of PUFA in their composition is a key 
feature in the structure-activity relationship, corroborating that fatty acyl composition 
is closely related with glycolipid bioactivity [13,28]. Previous studies have recognized 
bioactive effects in several molecular species of glycolipids that have been identified 
in the lipidome of S. latissima. For instance, the sulfolipids SQDG (20:5/16:0) was 
mentioned to have antitumoral activity as inhibitor of eukaryotic DNA polymerases 
[31], SQDG (16:0/16:0) and SQDG (18:0/14:0) with antiviral activity against herpes 
simplex virus (HSV-1 and HSV-2) and Coxsackie virus B3 (Cox B3) [32]; SQMG 
(16:0) and SQDG (18:2/16:0) have been referred to display high antitumoral activity 
against human breast carcinoma (MCF-7 cells) and human hepato carcinoma 
(HepG2), as well as antimicrobial activity, with a high growth inhibition of Bacillus 
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subtilis and Escherichia coli [33]. Moreover, galactolipids isolated from macroalgae 
have been reported to display bioactive proprieties. The MGDG (18:4/|16:0) and 
DGDG (20:5/16:0) identified in richness extract of polar lipids showed inhibition of 
nitric oxide production revealing their anti-inflammatory potential [18,34]. These 
glycolipids have been identified in the present study, as molecular species of S. 
latissima lipidome. Bioactive polar lipids molecules present in their structure C16 and 
C18 saturated and unsaturated fatty acids, and C20 PUFA [31,34]. These fatty acids are 
well documented for their health benefits to humans, specially the long chain n-3 fatty 
acids, such as α-linolenic (ALA, C18:3n-3), eicosapentaenoic (EPA, C20:5n-3) and 
docosahexaenoic acids (DHA, C22:6n-3) [35,36]. 
3.2 Phospholipid profile 
Analysis of HILIC-LC-MS allowed the identification of eight phospholipid classes 
and 120 molecular species. Additionally, a total of 12 molecular species of 
arsenolipids, concretely arsenic-containing phospholipids (AsPL), were also 
identified. 
PGs and LysoPGs (LPGs) were identified by HILIC-LC-MS in negative mode as [M - 
H]- ions (see Supplementary Figure S4). A total of 8 and 22 molecular species of 
LPGs and PG (Fig. 4) have been identified, respectively. The most abundant 
molecular species of LPG were the LPG (16:1) and LPG (16:0), correspond to [M - 
H]- ions at m/z 481.3 and m/z 483.3, respectively (Fig. 4). Furthermore, the most 
abundant molecular species of PG were PG (16:0/18:2) and PG (16:0/18:1), 
correspond to [M - H]- ions at m/z 745.5 and m/z 747.5, respectively (Fig. 4).  
Phosphatidylcholines (PC) and LysoPC (LPC) were observed as [M + H]+ ions in 
HILIC-LC-MS spectra and acyl chains were confirmed by HILIC-LC-MS/MS as [M 
+ CH3COO]- ions (see Supplementary Figure S5). The analysis of HILIC-LC-MS 
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spectra allowed the identification of 6 and 30 molecular species of LPC 
(Supplementary Table S2) and PC (Fig. 5), respectively. The most abundant 
molecular species of PC were PC (14:0/20:4) and PC (16:0/20:4), correspond to [M + 
H]+ ions at m/z 754.5 and m/z 782.6, respectively (Fig. 5). 
A total of 12 molecular species of phosphatidylethanolamines (PE) have been 
identified as [M + H]+ ions (Supplementary Figure S6). The most abundant molecular 
species of PE were PE (30:3) and PE (36:1), correspond to [M + H]+ ions at m/z 658.4 
and m/z 746.6, respectively (Supplementary Figure S6). 
Phosphatidylinositols (PI) and LysoPI (LPI) were analyzed in negative ion mode with 
the formation of [M - H]- ions. A total of 4 and 22 molecular species of LPI 
(Supplementary Figure S7) and PIs (Supplementary Figure S8) have been identified, 
respectively. The most abundant molecular species of PI were PI (14:0/18:3) and PI 
(16:0/18:1), correspond to [M - H]- ions at m/z 803.5 and 835.5, respectively 
(Supplementary Figure S7). 
Phosphatidic acid (PA) were analyzed by HILIC-LC-MS in negative-ion mode with 
the formation of [M - H]- ions. Overall, 16 molecular species have been identified, 
being the PA (14:0/16:0) the most abundant molecular species, corresponds to [M - 
H]- ion at m/z 619.4 (Supplementary Figure S9). 
AsPL were analyzed by HILIC-LC-MS in positive-ion mode with the formation of [M 
+ H]+ ions, and a total of 12 molecular species have been identified, being the ion 
AsPL (32:0) the most abundant, corresponding to [M + H]+ at m/z 959.5 
(Supplementary Figure S10). 
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[M-H]-
m/z
Lipid species 
(C:N) Fatty acyl chains
691.4550 PG(30:1) 14:0/16:1; 14:1/16:0
693.4710 PG(30:0) 14:0/16:0
717.4714 PG(32:2) 14:0/18:2;  16:1/16:1; 16:0/16:2
719.4861 PG(32:1) 16:0/16:1; 14:0/18:1
721.5025 PG(32:0) 16:0/16:0
739.4547 PG(34:5) 14:0/20:5; 16:3/18:2; 16:1/18:4; 14:1/20:4
741.4700 PG(34:4) 16:1/18:3; 14:0/20:4; 16:0/18:4
743.4863 PG(34:3) 16:0/18:3; 16:1/18:2 
745.5026 PG(34:2) 16:0/18:2; 16:1/18:1; 14:0/20:2
747.5187 PG(34:1) 16:0/18:1; 14:0/20:1
749.5336 PG(34:0) 16:0/18:0; 14:0/20:0
759.5147 PG(35:2) 16:1/19:1; 17:0/18:2
761.5335 PG(35:1) 16:0/19:1
763.5499 PG(35:0) 16:0/19:0
765.4717 PG(36:6) 18:3/18:3; 18:2/18:4; 16:1/20:5; 16:0/20:6
767.4866 PG(36:5) 18:2/18:3; 16:0/20:5; 16:1/20:4; 14:0/22:5
769.5027 PG(36:4) 18:2/18:2; 18:1/18:3; 16:0/20:4
771.5176 PG(36:3) 18:1/18:2; 16:0/20:3; 16:1/20:2
773.5332 PG(36:2) 18:1/18:1; 18:0/18:2; 16:0/20:2
775.5475 PG(36:1) 18:1/18:0; 16:0/20:1
795.5174 PG(38:5) 16:0/22:5; 18:0/20:5; 18:1/20:4; 18:2/20:3; 18:3/20:2
821.5329 PG(40:6) 18:1/22:5; 18:0/22:6; 20:2/20:4
[M-H]-
m/z
Lipid species
(C:N) Fatty acyl chain
481.2570 LPG(16:1) 16:1
483.2730 LPG(16:0) 16:0
505.2569 LPG(18:3) 18:3
507.2732 LPG(18:2) 18:2
509.2880 LPG(18:1) 18:1
529.2578 LPG(20:5) 20:5
535.3038 LPG(20:2) 20:2
557.2894 LPG(22:5) 22:5
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Figure 4 Lipidomic profile of phosphatidylglycerol (PG) and lysoPG (LPG) 
identified in Saccharina latissima samples. a) HILIC-ESI-MS spectrum of LPG 
showing the molecular species detected as [M -H]- ions. b) HILIC-ESI-MS spectrum 
of PG showing the molecular species detected as [M -H]- ions. c) Molecular species 
of LPG. d) Molecular species of PG (C represents the total number of carbon atoms 
and N the total number of double bonds on the fatty acyl chains; bold m/z values 
correspond to the most abundant molecular species detected in HILIC-ESI-MS 
spectrum).  
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[M+H]+
m/z
[M+CH3COO]-
m/z
Lipid species 
(C:N)
Fatty acyl chains
704.5249 762.5285 PC(30:1) **
726.5065 784.5128 PC(32:4) **
728.5233 786.5288 PC(32:3) 14:2/18:1; 14:1/18:2
730.5370 788.5425 PC(32:2) 14:0/18:2
732.5538 790.5593 PC(32:1) 14:0/18:1; 16:0/16:1
746.5667 804.5722 PC(33:1) 16:0/17:1; 14:0/19:1
752.5230 810.5285 PC(34:5) 14:0/20:5
754.5388 812.5443 PC(34:4) 14:0/20:4
756.5537 814.5592 PC(34:3) 14:0/20:3; 16:0/18:3
758.5707 816.5762 PC(34:2) 16:0/18:2; 16:1/18:1
760.5838 818.5893 PC(34:1) 16:1/18:0
768.5533 826.5588 PC(35:4) **
774.5065 832.5120 PC(36:8) 18:4/18:4
776.5200 834.5255 PC(36:7) 18:2/18:5; 16:1/20:6
778.5359 836.5414 PC(36:6) 18:1/18:5; 16:0/20:6; 16:2/20:4
780.5525 838.5580 PC(36:5) 16:0/20:5
782.5679 840.5734 PC(36:4) 16:0/20:4
784.5849 842.5904 PC(36:3) 16:0/20:3; 18:1/18:2; 18:0/18:3
786.6004 844.6059 PC(36:2) 18:1/18:1; 18:0/18:2; 16:0/20:2; 14:0/22:2
802.5370 860.5425 PC(38:8) 18:2/20:6
804.5516 862.5571 PC(38:7) 18:1/20:6; 18:3/20:4;  18:4/20:3; 18:5/20:2
806.5685 864.5740 PC(38:6) 18:2/20:4
808.5829 866.5884 PC(38:5) 18:1/20:4
810.5993 868.6048 PC(38:4) 18:0/20:4; 20:0/18:4
826.5384 884.5439 PC(40:10) 20:4/20:6
828.5539 886.5594 PC(40:9) 20:4/20:5
830.5698 888.5753 PC(40:8) 20:4/20:4
832.5840 890.5895 PC(40:7) 20:3/20:4; 20:2/20:5
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852.5538 910.5593 PC(42:11) 20:5/22:6
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Figure 5 Lipidomic profile of phosphatidylcholine (PC) identified in Saccharina 
latissima samples. a) HILIC-ESI-MS spectrum of PC showing the molecular species 
detected as [M +H]+ ions and b) [M +CH3COO]- ions. c) Molecular species of PC (C 
represents the total number of carbon atoms and N the total number of double bonds 
on the fatty acyl chains; bold m/z value corresponds to the most abundant molecular 
species detected in HILIC-ESI-MS spectrum). 
** Molecular species identified only by mass accuracy.  
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Phospholipids are recognized by their structural role in cell membranes, whose 
properties, such as fluidity, depend on their fatty acid composition. However, recent 
studies have identified phospholipids as a source of PUFA (e.g. n-3 fatty acids) by 
delivering their fatty acids, and even endorsed their therapeutic and beneficial health 
effects when they are ingested in the diet [37]. The use of phospholipids as source of 
PUFA was studied by Tang et al. [38], who have compared the efficiency of n-3 fatty 
acids absorption in the forms of free fatty acids, ethyl esters, esterified into 
triglycerides or phospholipids, in mice. Phospholipid bound n-3 fatty acids presented 
a superior bioavailability, increasing the concentration of DHA in the tissues analyzed 
(e.g. brain and liver), likely due to the amphiphilic character of these compounds and 
their interaction with cellular membranes [38,39]. Furthermore, phospholipid bound 
n-3 fatty acids was identified by decreasing hepatic and serum total cholesterol and 
triglycerides levels [38]. Therefore, phospholipids represent an available source of 
PUFA, providing beneficial nutritional effects through the transport of n-3 fatty acids, 
which for instance are essential to a healthy human brain or even protect against 
different diseases such as cancer, cardiovascular risks or neurological disorders 
[19,37]. 
Very few studies have addressed phospholipids bioactivity, although some molecular 
species of PG have been reported with anti-inflammatory proprieties. Banskota et al. 
[18] identified two PG molecular species with strong inhibitory activity against 
lipopolysaccharide induced nitric oxide production. One of these PG molecular 
species identified in this study [18] was the PG (16:0/20:5), which was also present in 
S. latissima lipidome identified in the present study. 
Arsenolipids were identified for the first time in the brown alga Undaria pinnatifida 
(wakame) [40]. This class of lipids occurs naturally in marine foods, such as fish and 
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macroalgae [41–43]. Their presence in S. latissima was already reported by Raab et 
al. [44], who suggested that they can related with the protection against peroxidation 
by intensive UV radiation and/or salinity changes, typical damages of macroalgae 
inhabiting intertidal environments. Although the presence of inorganic arsenic in 
water is considered an environmental health problem, few studies have addressed the 
toxicity of organic arsenic. Nevertheless, several studies have classified certain 
molecular species of arsenolipids (i.e. arsenic-containing hydrocarbons and arsenic-
containing fatty acids) as potentially cytotoxic for human cells, by their ability to 
cross the blood brain barrier (studies performed in the fruit fly Drosophila 
melanogaster) [45,46]. More toxicological studies are needed to evaluate the risk of 
these compounds. 
3.3 Betaine lipids 
Two classes of betaine lipids have been identified as [M + H]+ ions, 
monoacylglyceryl-N,N,N-trimethyl homoserine (MGTS) and diacylglyceryl-N,N,N-
trimethyl homoserine (DGTS). One molecular species of MGTS was identified 
MGTS (16:2), corresponds to the m/z [M + H]+ ion at 470.4. Furthermore, 7 molecular 
species of DGTS were identified, being DGTS (18:1/16:1) the most abundant and 
corresponding to the m/z [M + H]+ ion at 736.6 (Supplementary Figure S11). 
Betaine lipids are widely distributed in algae, where they display different functions 
as donors of diacylglycerols and fatty acids to be used in the biosynthesis of other 
lipid classes [47].  
3.4 Fatty acid profile 
Analysis by GC-MS showed that total fatty acid content represented 2.8 ± 0.3 µg mg 
DW -1, corresponding with 15.2% ± 2.5 of total lipid extract and 0.3% ± 0.0 of total 
biomass. The fatty acid profile of S. latissima displayed C16:0 and C18:0 (0.8 ± 0.2 and 
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0.4 ± 0.2 µg mg DW -1, respectively) as the most abundant fatty acids, representing 
29.4 % ± 3.0 and 15.5 % ± 4.6 of total fatty acid content, respectively (Fig. 6). 
Additionally, relevant PUFA have been identified, such as C18:2n-6 (0.2 ± 0.0 µg mg 
DW -1, 6.5% ± 1.3), C18:3n-3 (0.1 ± 0.0 µg mg DW -1, 3.5% ± 0.5), C18:4n-3 (0.1 ± 0.0 µg 
mg DW -1, 4.6% ± 0.7), C20:4n-6 (0.2 ± 0.0 µg mg DW -1, 5.6% ± 1.0) and C20:5n-3 (0.2 
± 0.0 µg mg DW -1, 5.5% ± 0.8). Saccharina latissima samples showed a n-6/n-3 ratio 
of 0.9 ± 0.1. 
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Figure 6 Fatty acid profile of Saccharina latissima samples as µg mg dry weight -1 
(DW) x 10-3, determined by GC-MS analysis of five samples (n = 5). 
 
 
 
 
 
 
 
 
 
 
Figure 6 Fatty acid profile of Saccharina latissima samples as µg mg dry weight -1 
(DW), determined by GC-MS analysis of five samples (n = 5). 
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This macroalga revealed to be a rich source of PUFA and, as referred above, these are 
mainly esterified in polar lipid molecular species (e.g. glycolipids and phospholipids). 
Essential PUFA are critical lipids that must be obtained from dietary sources to 
sustain homeostasis, being marine macroalgae one of their natural sources [48]. 
Humans, as most animals, lack the ability to synthesize linoleic (LnA, C18:2n-6) and 
ALA. The latter is the precursor of two physiologically essential fatty acids, EPA and 
DHA. Nevertheless, humans have a limited ability to desaturate and elongate the 
precursors of these fatty acids to fulfil their own demand. Therefore, certain PUFA 
such as EPA and DHA must be supplied through the diet, being seaweed a rich source 
of these PUFA. Nowadays, western diets present high levels of n-6 PUFA, with a 
nutritional ratio n-6/n-3 greater than 2, which has been associated with increasing 
risks of mortality due to cancer, cardiovascular, inflammatory and autoimmune 
diseases [49]. However, marine macroalgae, such as S. latissima, present a much 
higher prevalence of n-3 PUFA than land vegetables. A diet rich in n-3 PUFA can 
reduce n-6/n-3 ratio, being nutritionally more healthful and contributing to the 
prevention of chronic diseases [36,50]. Several studies have demonstrated the 
nutritional value of n-3 PUFA and the health benefits associated with their 
consumption [12,36,38,50]. Additionally, n-3 PUFA play a relevant role in the normal 
development and functioning of brain and central nervous system, being involved in 
memory formation and neuronal signaling [36,51]. The protective role of n-3 PUFA 
has proved to be crucial during early brain development stages, suggesting that a low 
consumption of these PUFA during childhood may be associated with neurocognitive 
disorders [52]. 
4. Conclusions  
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Lipidome characterization of S. latissima was performed by the identification of 197 
molecular species of polar lipids, including glycolipids, phospholipids and betaine 
lipids, some of which have been recognized by their bioactivity. This study endorses 
S. latissima as a promising source of natural bioactive lipid compounds with potential 
health and therapeutic benefits. Furthermore, this macroalgae is featured by its high 
nutritional value as a source of PUFA and low n-6/n-3 ratio. Saccharina latissima is 
an emerging candidate to promote blue biotechnology inspired by the ocean, with 
applications in food, feed and nutraceutical industries. 
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